Science
Remdesivir is more effective for COVID-19 than standard treatment – The Times Hub
Investing.com – A study by biotech company Gilead Sciences Inc (NASDAQ: GILD) found that a short, 5-day course of treatment of moderately severe hospitalized patients
Investing.com – A study by biotech company Gilead Sciences Inc (NASDAQ: GILD) found that a short, 5-day course of treatment of moderately severe hospitalized patients with COVID-19 with experimental remdesivir was more effective than 10 days and than standard treatment, writes Market Watch.
The results of the third phase of the open-label studies were published in the American scientific journal of the medical association JAMA. The company has already received permission for emergency use of …
-
Noosa News18 hours agoWhat instrument did Japan’s heavy-metal PM play? Take the Brisbane Times Quiz
-
Business10 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Noosa News23 hours agoBasic cyber steps can block most attacks – Proctor
-
Noosa News21 hours agoCompetition watchdog approves Elders’ $475m acquisition of agribusiness rival Delta